Organisation | Amount | Year | Notes |
---|---|---|---|
National Institute for Health Research | £24.9 million | 2012–2013 | 3.4% of total disease-specific research spend (£732 million) |
Medical Research Council | £21.1 million | 2013–2014 | 2.5% of total research spend (£845 million) |
Wellcome Trust | £20.6 million | 2012–2013 | 2.8% of total charitable spend (£726 million) |
Cancer Research UK | £16 million | 2013–2014 | Lung cancer: 4.5% of total research spend (£351 million) |
Cystic Fibrosis Trust | £4.1 million | 2013–2014 | Spend on cystic fibrosis research |
Asthma UK | £2.9 million | 2012–2013 | Spend on asthma research |
NC3Rs | £1.8 million | 2014 | Research grants focusing solely on respiratory disease |
Medical Research Foundation | £1.6 million | 2014–2015 | Joint spend with Asthma UK |
Roy Castle Lung Cancer Foundation | £1.2 million | 2013 | Spend on lung cancer research |
British Lung Foundation | £1.1 million | 2012–2013 | All lung diseases |
Action Medical Research | £198 473 | 2015 | Primary ciliary dyskinesia research |
June Hancock Mesothelioma Research Fund | £170 891 | 2013–2014 | Spend on mesothelioma research |
Henry Smith Charity | £120 000 | 2014 | CF (via Action Medical Research) |
British Medical Association | £110 000 | 2014 | £60 000 asthma, £50 000 viral respiratory infection |
Chest, Heart & Stroke Scotland | £59 965 | 2014 | Spend on asthma |
Northern Ireland Chest Heart & Stroke | £18 974 | 2013 | Spend on research into RSV infection |
Total annual spend ∼£96 million (excludes national DHs, NHS, smaller charities and the pharma industry).
CF, cystic fibrosis; DH, Department of Health; NC3Rs, the National Centre for the Replacement, Refinement and Reduction of Animals in Research; RSV, respiratory syncytial virus.